MedTrace Logo

Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)

NCT00888433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2015-05-20

Study results available
· View outcomes & findings →

Summary

An international, multi-center, prospective, randomized, controlled study of the safety and effectiveness of renal denervation in patients with uncontrolled hypertension.

Conditions

Interventions

DEVICE

Renal Denervation (Symplicity® Renal Denervation System)

Catheter-based renal denervation

Sponsors & Collaborators

  • Medtronic Vascular

    lead INDUSTRY

Principal Investigators

  • Murray Esler, MBBS · The Baker IDI Heart & Diabetes Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-09-30
Completion
2015-05-31

Countries

  • Australia
  • Austria
  • Belgium
  • France
  • Germany
  • Latvia
  • Poland
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00888433 on ClinicalTrials.gov